What Is a Normal AMH Level in Pregnancy?

What Is a Normal AMH Level in Pregnancy?

AMH (anti-Müllerian hormone) is not routinely measured during pregnancy, and there is no established "normal" range for pregnant women the way there is for follicle counts or progesterone. In early pregnancy, AMH levels drop noticeably — sometimes to near-undetectable values — and this is physiologically expected, not a warning sign. The exception is women with very high pre-conception AMH (as seen in PCOS), whose levels may remain elevated longer into the first trimester.

---

What AMH Actually Measures — and Why Pregnancy Changes It

Anti-Müllerian hormone is produced almost exclusively by the granulosa cells of small antral and pre-antral follicles in the ovary. Because it reflects the pool of growing follicles, it is used clinically as the best available marker of ovarian reserve — how many eggs a woman has remaining relative to her age (Dewailly et al., Human Reproduction Update 2014; PMID: 24430863).

Once pregnancy is established, several things happen to AMH:

• Ovarian follicle activity is suppressed by rising hCG and progesterone
• The dominant follicle has already been selected and ovulated
• Granulosa cell activity slows dramatically
• Circulating AMH levels decline, often reaching their nadir in the late first trimester

A study published in Fertility and Sterility found that serum AMH drops by approximately 25–50% during the first trimester of a singleton pregnancy compared to pre-conception values, with some women showing levels below the detectable threshold of common assays (La Marca et al., Fertility and Sterility 2010; PMID: 19939376). This suppression is temporary — levels typically recover toward baseline within a few months postpartum.

This is why measuring AMH during pregnancy yields a number that cannot be directly compared to standard ovarian reserve reference ranges. Those ranges were built on data from non-pregnant women.

---

Reference Ranges for AMH Before vs. During Pregnancy

To put pregnancy values in context, it helps to understand the standard pre-conception benchmarks:

Note: These are Elecsys/Roche assay-based approximate ranges; lab-specific reference intervals vary.

During pregnancy, circulating AMH may fall well below these benchmarks and still represent a completely healthy, ongoing pregnancy. There is no validated "normal AMH range in pregnancy" published by major reproductive endocrinology societies (ASRM, ESHRE) because AMH is not a pregnancy monitoring biomarker.

---

Why Your AMH May Have Been Tested During Pregnancy

Most women who ask about AMH in pregnancy fall into one of three groups:

1. They had AMH drawn before confirming pregnancy — a pre-conception panel result arrived after they tested positive, creating confusion.
2. Their fertility clinic continued monitoring — some IVF/ART protocols include repeated hormone panels in early pregnancy as part of research protocols or comprehensive care.
3. They have PCOS — women with polycystic ovarian syndrome often have AMH levels two to four times above the typical range before conception. For this group, understanding normal AMH levels with PCOS is an important baseline before interpreting any pregnancy-era result.

If you received a low AMH result early in your first trimester, this does not mean your ovarian reserve has permanently declined or that the pregnancy is compromised. The two things are not causally linked in the way many people assume.

---

Does Low AMH Before Conception Affect Pregnancy Outcomes?

This is one of the most clinically important questions — and the answer is more nuanced than the fertility industry often conveys.

Low AMH before conception is a predictor of lower egg yield in IVF stimulation cycles and a marker of reduced ovarian reserve. It does not, by itself, predict:

• Whether natural conception is possible
• Miscarriage risk once pregnancy is achieved
• Fetal health or chromosomal outcomes
• Live birth rate in women who do conceive

A prospective cohort study published in JAMA (Steward et al., 2017; PMID: 28535237) followed over 750 women aged 30–44 trying to conceive naturally. Women with low AMH had similar cumulative pregnancy rates over 12 months as women with normal AMH — suggesting that in natural conception, AMH is not a reliable barrier to pregnancy when other fertility factors are intact.

Separately, a systematic review in Human Reproduction found no statistically significant association between pre-conception AMH and miscarriage risk in women who achieved spontaneous pregnancy (Iliodromiti et al., Human Reproduction 2015; PMID: 26113063).

What low AMH does meaningfully predict is response to ovarian stimulation — which is why it matters so much in IVF contexts, but far less in natural conception scenarios.

---

High AMH in Pregnancy: What Does It Mean?

High pre-conception AMH (above 6.8 ng/mL or, in PCOS, sometimes above 10 ng/mL) reflects a larger pool of resting follicles. During early pregnancy, these women may still show AMH values above typical non-PCOS ranges, simply because their pre-pregnancy baseline was elevated.

High AMH in pregnancy is not associated with adverse outcomes in most research. One area of ongoing study is whether very high AMH levels (seen in severe PCOS) correlate with OHSS risk during IVF or with altered hormonal environment in early pregnancy — but these effects are IVF-specific and do not apply to spontaneous pregnancies.

If you were diagnosed with PCOS before conceiving, understanding how AMH interacts with that diagnosis is valuable context. Vitamin D status has also been shown to influence AMH signaling in women with PCOS — a topic explored in our article on vitamin D levels and PCOS.

---

AMH and Other Hormones Worth Monitoring in Pregnancy

While AMH is not a standard pregnancy panel marker, several other lab values are routinely tracked and matter significantly for maternal and fetal health. These interact with the same hormonal and nutritional systems that influence AMH regulation:

• Vitamin D (25-OH): Vitamin D receptors are expressed on ovarian granulosa cells; deficiency is associated with lower AMH in some populations. During pregnancy, adequate D3 status is essential for fetal bone development and immune programming. See our coverage of postpartum vitamin D levels for context on how levels shift after delivery.
• Zinc: Plays a structural role in ovarian steroidogenesis and immune function. See what constitutes a normal zinc level in pregnancy to understand whether your levels are in range.
• Folate: Critical for neural tube development in the first trimester. Normal folate levels in pregnancy are tightly defined and tested routinely.
• Magnesium: Supports progesterone synthesis, blood pressure regulation, and reduces preterm labor risk.

Thinking about AMH in isolation misses how deeply interconnected these markers are during the periconceptional and early pregnancy periods.

---

Can Anything Be Done to Support AMH or Ovarian Reserve?

This is a question many women ask, especially after receiving a low AMH result pre-pregnancy. The honest answer is that no supplement or lifestyle intervention has been shown in high-quality randomized trials to meaningfully increase AMH in women with confirmed diminished ovarian reserve. However, several areas of research suggest modifiable factors can influence the hormonal environment around ovarian function:

Vitamin D repletion: Several observational studies link vitamin D sufficiency with higher AMH in women with PCOS and in the general population. A 2015 randomized trial in Journal of Clinical Endocrinology & Metabolism found that vitamin D supplementation increased AMH in PCOS women who were deficient (Dennis et al., 2015; PMID: 25768671). This is not the same as restoring reserve in a woman with diminished ovarian reserve due to age.

CoQ10/Ubiquinol: Mitochondrial function in oocytes declines with age. Ubiquinol (the active form of CoQ10) has been investigated as a means of supporting oocyte energy metabolism, particularly in women over 35. A small RCT published in Fertility and Sterility found improved embryo quality in poor responders supplementing CoQ10 (Xu et al., 2018; PMID: 29935638). AMH was not the outcome measured, but ovarian response was.

Omega-3 fatty acids: Anti-inflammatory EPA/DHA may support the follicular microenvironment. Observational data associates higher omega-3 intake with higher AMH in reproductive-age women, though intervention data is limited.

None of these interventions should be interpreted as a path to "raising" AMH to a target number. They are supportive of the broader hormonal and cellular environment — not direct AMH modulators.

---

What This Means for Your Formula

If you are in the preconception phase and your AMH has come back low or borderline, a personalized supplement plan built around your full lab picture — not just AMH — is a more rational approach than guessing at individual products.

Ones analyzes your blood panel, wearable data, and health history to build a custom daily capsule formula calibrated to your specific findings. For women with concerns around ovarian function and hormonal balance, relevant ingredients in the Ones catalog include:

• Ubiquinol (CoQ10, 200mg): At the dose used in oocyte quality research, supporting mitochondrial function in aging reproductive cells.
• Vitamin D3 + K2 (MK-7): Dosed to clinical sufficiency targets, addressing the vitamin D–AMH relationship documented in PCOS and general population studies.
• Omega-3 (EPA/DHA): Supporting the anti-inflammatory follicular environment, with doses calibrated to your baseline omega-3 index if available from your labs.

Ones does not stock AMH-raising compounds (because no such compound has met the clinical bar for inclusion). What the platform does is address the modifiable nutritional gaps that influence the hormonal systems around ovarian health — without overpromising on what a supplement can do.

---

Key Takeaways

• AMH is not a standard pregnancy biomarker. There is no validated "normal AMH range in pregnancy" — levels drop during the first trimester as a normal physiological response to conception.
• A low AMH result drawn in early pregnancy does not indicate a pregnancy complication. The decline is expected and temporary.
• Pre-conception AMH predicts ovarian stimulation response in IVF, not natural conception success or miscarriage risk — major prospective studies support this distinction.
• Women with PCOS may have elevated AMH that persists longer into pregnancy — this is expected given their pre-conception baseline, not a cause for alarm.
• Other pregnancy lab markers — zinc, folate, magnesium, vitamin D — are clinically more actionable during pregnancy than AMH and should be the focus of your monitoring.
• No supplement has been proven to meaningfully raise AMH in women with diminished ovarian reserve, but certain nutrients (vitamin D, CoQ10, omega-3) support the broader hormonal and cellular environment relevant to ovarian health.

---

Always consult your reproductive endocrinologist or OB-GYN before making changes to your supplement protocol during pregnancy. The information here is educational and does not constitute medical advice.